title: Costimulation Blockade Holds Emerging Hope for Patients in Large Markets Only.
authors.affiliation: Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: J S
authors.initials: JS
authors.lastname: Gill
authors.affiliation: Division of Nephrology & Transplant Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: P
authors.identifier: 0000-0003-1371-1947
authors.initials: P
authors.lastname: Halloran
authors.affiliation: Division of Nephrology and Transplantation, Department of Medicine, University of Western Ontario, London, Ontario, Canada.
authors.forename: T
authors.initials: T
authors.lastname: Jevnikar
authors.affiliation: University Health Network, Toronto General Hospital, Toronto, Ontario, Canada.
authors.forename: E
authors.initials: E
authors.lastname: Cole
authors.affiliation: Internal Medicine/Nephrology, Health Sciences Centre, Winnipeg, Manitoba, Canada.
authors.forename: D
authors.initials: D
authors.lastname: Rush
authors.affiliation: Division of Nephrology, Department of Medicine, Ottawa General Hospital, Ottawa, ON, Canada.
authors.forename: G
authors.initials: G
authors.lastname: Knoll
mesh_terms: D000069594:Abatacept; D016572:Cyclosporine; D006085:Graft Survival; D006801:Humans; D014019:Tissue Donors
chemical_list: D000069594:Abatacept; D016572:Cyclosporine
keywords: clinical research/practice; economics; immunosuppressant; kidney transplantation/nephrology; other